Autoantibody Profiles in the Sera of European Patients with Myositis

Overview

Journal Ann Rheum Dis

Specialty Rheumatology

Date 2001 Jan 13

PMID 11156543

Citations 103

Authors

R Brouwer

G J Hengstman

W Vree Egberts

H Ehrfeld

B Bozic

A Ghirardello

G Grondal

M Hietarinta

D Isenberg

J R Kalden

I Lundberg

H Moutsopoulos

P Roux-Lombard

J Vencovsky

A Wikman

H P Seelig

B G van Engelen

W J van Venrooij

Affiliations

Soon will be listed here.

Abstract

Objective: To determine the prevalence of myositis specific autoantibodies (MSAs) and several myositis associated autoantibodies (MAAs) in a large group of patients with myositis.

Methods: A total of 417 patients with myositis from 11 European countries (198 patients with polymyositis (PM), 181 with dermatomyositis (DM), and 38 with inclusion body myositis (IBM)) were serologically analysed by immunoblot, enzyme linked immunosorbent assay (ELISA) and/or immunoprecipitation.

Results: Autoantibodies were found in 232 sera (56%), including 157 samples (38%) which contained MSAs. The most commonly detected MSA was anti-Jo-1 (18%). Other anti-synthetase, anti-Mi-2, and anti-SRP autoantibodies were found in 3%, 14%, and 5% of the sera, respectively. A relatively high number of anti-Mi-2 positive PM sera were found (9% of PM sera). The most commonly detected MAA was anti-Ro52 (25%). Anti-PM/Scl-100, anti-PM/Scl-75, anti-Mas, anti-Ro60, anti-La, and anti-U1 snRNP autoantibodies were present in 6%, 3%, 2%, 4%, 5%, and 6% of the sera, respectively. Remarkable associations were noticed between anti-Ro52 and anti-Jo-1 autoantibodies and, in a few sera, also between anti-Jo-1 and anti-SRP or anti-Mi-2 autoantibodies.

Conclusions: The incidence of most of the tested autoantibody activities in this large group of European patients is in agreement with similar studies of Japanese and American patients. The relatively high number of PM sera with anti-Mi-2 reactivity may be explained by the use of multiple recombinant fragments spanning the complete antigen. Furthermore, our data show that some sera may contain more than one type of MSA and confirm the strong association of anti-Ro52 with anti-Jo-1 reactivity.

Citing Articles

Refractory Severe Anti-SRP Myopathy that Improved with Long-term Rehabilitation Therapy: A Case Report.

Nakao Y, Ibe Y, Tazawa M, Arii H, Toyama R, Shirayoshi T Prog Rehabil Med. 2025; 10():20250003.

PMID: 39845980 PMC: 11745824. DOI: 10.2490/prm.20250003.

Clinical characteristics of idiopathic inflammatory myopathies related to anti-SRP: a single center experience.

Tang Q, Xie X, He J, Li F, Chen J, Mao N Sci Rep. 2024; 14(1):25788.

PMID: 39468198 PMC: 11519947. DOI: 10.1038/s41598-024-74940-1.

Association of anti-Ro-52 antibodies with occurrence of interstitial lung disease in patients with idiopathic inflammatory myopathy.

Weng C, Huang T, Wu C, Sun Y Arthritis Res Ther. 2024; 26(1):152.

PMID: 39175076 PMC: 11340136. DOI: 10.1186/s13075-024-03382-x.

Roles of TRIM21/Ro52 in connective tissue disease-associated interstitial lung diseases.

Gong X, He S, Cai P Front Immunol. 2024; 15:1435525.

PMID: 39165359 PMC: 11333224. DOI: 10.3389/fimmu.2024.1435525.

Distinct Transcript-Level Expression Profiles and Unique Alternative Splicing in Inflammatory Myopathies.

Najjar R, Alessi H, Pinal-Fernandez I, Mammen A, Mustelin T ACR Open Rheumatol. 2024; 6(10):690-699.

PMID: 39073022 PMC: 11471943. DOI: 10.1002/acr2.11724.

References

Ben-Chetrit E, Fox R, Tan E . Dissociation of immune responses to the SS-A (Ro) 52-kd and 60-kd polypeptides in systemic lupus erythematosus and Sjögren's syndrome. Arthritis Rheum. 1990; 33(3):349-55. DOI: 10.1002/art.1780330307. View

Targoff I, Johnson A, Miller F . Antibody to signal recognition particle in polymyositis. Arthritis Rheum. 1990; 33(9):1361-70. DOI: 10.1002/art.1780330908. View

Alderuccio F, Chan E, Tan E . Molecular characterization of an autoantigen of PM-Scl in the polymyositis/scleroderma overlap syndrome: a unique and complete human cDNA encoding an apparent 75-kD acidic protein of the nucleolar complex. J Exp Med. 1991; 173(4):941-52. PMC: 2190817. DOI: 10.1084/jem.173.4.941. View

Dalakas M . Polymyositis, dermatomyositis and inclusion-body myositis. N Engl J Med. 1991; 325(21):1487-98. DOI: 10.1056/NEJM199111213252107. View

Leff R, Burgess S, Miller F, Love L, Targoff I, Dalakas M . Distinct seasonal patterns in the onset of adult idiopathic inflammatory myopathy in patients with anti-Jo-1 and anti-signal recognition particle autoantibodies. Arthritis Rheum. 1991; 34(11):1391-6. DOI: 10.1002/art.1780341108. View

Love L, Leff R, Fraser D, Targoff I, Dalakas M, Plotz P . A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups. Medicine (Baltimore). 1991; 70(6):360-74. DOI: 10.1097/00005792-199111000-00002. View

Miller F . Humoral immunity and immunogenetics in the idiopathic inflammatory myopathies. Curr Opin Rheumatol. 1991; 3(6):902-10. DOI: 10.1097/00002281-199112000-00002. View

Hirakata M, Mimori T, Akizuki M, Craft J, Hardin J, Homma M . Autoantibodies to small nuclear and cytoplasmic ribonucleoproteins in Japanese patients with inflammatory muscle disease. Arthritis Rheum. 1992; 35(4):449-56. DOI: 10.1002/art.1780350415. View

Ge Q, FRANK M, OBrien C, Targoff I . Cloning of a complementary DNA coding for the 100-kD antigenic protein of the PM-Scl autoantigen. J Clin Invest. 1992; 90(2):559-70. PMC: 443135. DOI: 10.1172/JCI115895. View

10.

Bluthner M, BAUTZ F . Cloning and characterization of the cDNA coding for a polymyositis-scleroderma overlap syndrome-related nucleolar 100-kD protein. J Exp Med. 1992; 176(4):973-80. PMC: 2119404. DOI: 10.1084/jem.176.4.973. View

11.

Gelpi C, Sontheimer E, Rodriguez-Sanchez J . Autoantibodies against a serine tRNA-protein complex implicated in cotranslational selenocysteine insertion. Proc Natl Acad Sci U S A. 1992; 89(20):9739-43. PMC: 50208. DOI: 10.1073/pnas.89.20.9739. View

12.

Oddis C, Okano Y, Rudert W, Trucco M, Duquesnoy R, Medsger Jr T . Serum autoantibody to the nucleolar antigen PM-Scl. Clinical and immunogenetic associations. Arthritis Rheum. 1992; 35(10):1211-7. DOI: 10.1002/art.1780351014. View

13.

Lundberg I, Nennesmo I, Hedfors E . A clinical, serological, and histopathological study of myositis patients with and without anti-RNP antibodies. Semin Arthritis Rheum. 1992; 22(2):127-38. DOI: 10.1016/0049-0172(92)90006-y. View

14.

Kalovidouris A . Immune aspects of myositis. Curr Opin Rheumatol. 1992; 4(6):809-14. View

15.

Lutcke H, Dobberstein B . Structure and function of signal recognition particle (SRP). Mol Biol Rep. 1993; 18(2):143-7. DOI: 10.1007/BF00986769. View

16.

Koh E, Seow A, Ong B, Ratnagopal P, Tjia H, Chng H . Adult onset polymyositis/dermatomyositis: clinical and laboratory features and treatment response in 75 patients. Ann Rheum Dis. 1993; 52(12):857-61. PMC: 1005215. DOI: 10.1136/ard.52.12.857. View

17.

Ge Q, Nilasena D, OBrien C, FRANK M, Targoff I . Molecular analysis of a major antigenic region of the 240-kD protein of Mi-2 autoantigen. J Clin Invest. 1995; 96(4):1730-7. PMC: 185809. DOI: 10.1172/JCI118218. View

18.

Seelig H, Moosbrugger I, Ehrfeld H, Fink T, Renz M, Genth E . The major dermatomyositis-specific Mi-2 autoantigen is a presumed helicase involved in transcriptional activation. Arthritis Rheum. 1995; 38(10):1389-99. DOI: 10.1002/art.1780381006. View

19.

Low S, Berry M . Knowing when not to stop: selenocysteine incorporation in eukaryotes. Trends Biochem Sci. 1996; 21(6):203-8. View

20.

Arnett F, Targoff I, Mimori T, Goldstein R, Warner N, Reveille J . Interrelationship of major histocompatibility complex class II alleles and autoantibodies in four ethnic groups with various forms of myositis. Arthritis Rheum. 1996; 39(9):1507-18. DOI: 10.1002/art.1780390910. View